Ending Opioids by Photobiomodulation

James Carroll, CEO and founder of THOR Photomedicine – Speech to Congress.

We are all aware there is an opioid crisis.

  • A hundred million adults in the United States are affected by chronic pain and $600 billion a year is spent on in direct health care costs and lost productivity because of pain.
  • 49,000 people died from opioids in 2017.
  • 19,000 of which were from prescribed opioids for pain relief.

We believe that Photobiomodulation therapy can help reduce the prescribing of opioid medication for pain relief and we wish to draw attention to the Congress and health care policymakers, NIH and CMS, about this potentially valuable tool.

Read the full Speech to Congress on citizenoversight.blogspot.com

View Congressional Briefing Highlight Video

James Carroll, CEO and founder of THOR Photomedicine

This entry was posted in Industry, THE FUTURE OF LLLT. Bookmark the permalink.

One Response to Ending Opioids by Photobiomodulation

  1. Beth Lutjen says:

    It definitely helps reduce inflammation and pain. Improves mood. Decreases seasonal depression. Congress needs to make FDA approve at more non-pharmecuetical treatments and insurance needs to pay for it.

Leave a Reply

Your email address will not be published. Required fields are marked *